Delivery Order 36F79721D0141-36C24524N0243
Award Date 12/27/23
Potential Completion Date 12/29/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to a facility in Bartlett, Tennessee to support VHA's Veterans Integrated Service Network 5. The firm fixed price order runs from October 20th through the 24th of 2023. The contract utilizes...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a division of the Recordati Group, for the pharmaceutical product Signifor LAR 40 mg. The contract has a ceiling value of $10,811.24 and an ultimate completion date of November 22, 2024. This delivery order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's...
- The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group, for the provision of Signifor LAR 40 mg. The order, valued at $10,811.24, is being delivered under Recordati's Federal Supply Schedule (FSS-61-IB) contract with the VA, a five-year, $15.6 million indefinite-delivery vehicle established in April 2021. The contract does not include a set-aside designation, reflecting...
- Recordati Rare Diseases Inc. received a firm fixed-price delivery order award of $33.7K from the Department of Veterans Affairs' Veterans Integrated Service Network 5 for Signifor LAR 20 and 40 mg pharmaceutical products. The award was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and will be performed in Bartlett, Tennessee. This delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $21,623.35 firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide SIGNIFOR LAR 30 MG AND 40 MG for the agency's Veterans Integrated Service Network 5. This delivery order is placed against Recordati's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as well as a $3.1 million Blanket Purchase...
- The Department of Veterans Affairs Veterans Health Administration awarded a $43,493.16 delivery order to Recordati Rare Diseases, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for pasireotide in 20 mg and 40 mg doses to be delivered to a VA facility in Bartlett, Tennessee between July 24-27, 2023. Recordati Rare Diseases will provide the specialty pharmaceutical products to support VHA's care and services for veterans. As the prime contractor, Recordati...
- This is a $43,266.00 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Recordati Rare Diseases Inc. to provide SIGNIFOR LAR 30 MG AND 40 MG pharmaceuticals. The contract is issued against Recordati's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a firm fixed price delivery order with a completion date of April 16, 2024. No set-aside designation was used. Recordati Rare Diseases Inc. is a foreign-owned, for-profit...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $22,438.42 contract is for the drug SIGNIFOR LAR 40 MG and is part of the company's broader Federal Supply Schedule (FSS-61-IB) contract with the VA, valued at $15.6 million, as well as a $3,156,115 Blanket Purchase Agreement covering multiple rare disease treatments. The award has no set-aside...
- Recordati Rare Diseases Inc. was awarded a $21,622.48 firm fixed price delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The delivery order has a completion date of February 27, 2024 and was issued on February 23, 2024. Recordati holds two key indefinite-delivery vehicles for supplying pharmaceuticals to VA, including a...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $22,438.42, is for the supply of Signifor LAR 40 mg, an orphan drug used to treat rare medical conditions. The contract was awarded under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, and has an ultimate completion date of April 8, 2025. The...